Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

Molecular Psychiatry

Volumn 9, Issue 3, 2004, Pages 278-286

  Alonso, R ^a   Griebel, G ^b   Pavone, G ^a   Stemmelin, J ^b   Le Fur, G ^b   Soubrie P ^a  

^a SANOFI   (France)

^b NONE   (France)

Author keywords

Corticotrophin; Depression; Hippocampus; Vasopressin

Indexed keywords

1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; 4 (2 CHLORO 4 METHOXY 5 METHYLPHENYL) N [2 CYCLOPROPYL 1 (3 FLUORO 4 METHYLPHENYL)ETHYL] 5 METHYL N (2 PROPYNYL) 2 THIAZOLAMINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; FLUOXETINE; SSR 1149415; UNCLASSIFIED DRUG; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PREDICTION; PRIORITY JOURNAL; STRESS; VALIDATION PROCESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; FLUOXETINE; INDOLES; MALE; MICE; MICE, INBRED BALB C; NEURONS; PYRROLIDINES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, VASOPRESSIN; STRESS, PSYCHOLOGICAL; THIAZOLES;

EID: 1942502215     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001464     Document Type: Article

References (49)

1. Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, Peterson DA et al. Neurogenesis in the adult human hippocampus. Nat Med 1998; 4: 1313-1317.
2. Gross CG. Neurogenesis in the adult brain: death of a dogma. Nat Rev Neurosci 2000; 1: 67-73.
3. Gould E, Gross CG. Neurogenesis in adult mammals: some progress and problems. J Neurosci 2002; 22: 619-623.
4. Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 1997; 17: 2492-2498.
5. Gould E, Tanapat P, McEwen BS, Flügge G, Fuchs E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 1998; 95; 3168-3171.
6. Tanapat T, Galea LA, Gould E. Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus. Int J Dev Neurosci 1998; 16: 235-239.
7. Lemaire V, Koehl M, Le Moal M, Abrous DN. Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci USA 2000; 97: 11032-11037.
8. Pham K, Nacher J, Hof PR, McEwen BS. Repeated restaint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci 2003; 17: 879-886.
9. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104-9110.
10. Manev H, Uz T, Smalheiser NR, Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neuronal cultures in vitro. Eur J Pharmacol 2001; 411: 67-70.
11. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999; 46: 1181-1191.
12. Jacobs BL, Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 2000; 5: 262-269.
13. Kempermann G. Regulation of adult hippocampal neurogenesis - implications for novel theories of major depression. Bipolar Disord 2002; 4: 17-33.
14. Cameron HA, Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 1994; 61: 203-209.
15. Rodriguez JJ, Montaron MF, Petry KG, Aurousseau C, Marinelli M, Premier S et al. Complex regulation of the expression of the polysialylated form of the neuronal cell adhesion molecule by glucocorticoids in the rat hippocampus. Eur J Neurosci 1998; 10: 2994-3006.
16. Holsboer F. The rationale for corticotrophin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 1999; 33: 181-214.
17. Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 2000; 96: 23-29.
18. Reul JM, Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2002; 2: 23-33.
19. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders. Pharmacol Ther 1999; 82: 1-61.
20. Serradeil-Le Gal C, Wagnon J, Simiand J, Griebel G, Lacour C, Guillon G et al. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl] -3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N, N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. J Pharmacol Exp Ther 2002; 300: 1122-1130.
21. 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci USA 2002; 99: 6370-6375.
22. Griebel G, Simiand J, Steinberg R, Jung M, Gully D, Roger P et al. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4- methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. J Pharmacol Exp Ther 2002; 301: 333-345.
23. Keck ME, Welt T, Muller MB, Uhr M, Ohl F, Wigger A et al. Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 2003; 28: 235-243.
24. Wilner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997; 134: 319-329.
25. Kopp C, Vogel E, Rettori MC, Delagrange P, Misslin R. The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H/He mice. Behav Pharmacol 1999; 10: 73-83.
26. Czéh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, Van Kampen M et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 2001; 98: 12796-12801.
27. Van De Hart MG, Czeh B, De Biurrun G, Michaelis T, Watanabe T, Natt O et al. Substance P receptor antagonist and clomipramine prevent stress-induced alteration in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol Psychiatry 2002; 7: 933-941.
28. Takahashi T, Nowakowski RS, Caviness Jr VS. BUdR as an S-phase marker for quantitative studies of cytokinetic behaviour in the murine cerebral ventricular zone. J Neurocytol 1992; 21: 185-197.
29. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, 1997.
30. Eisch AJ, Barrot M, Schad CA, Self DW, Nestler EJ. Opiates inhinbit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci USA 2000; 97: 7579-7584.
31. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivision of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231: 482-497.
32. Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J Neurosi 2002; 22: 629-634.
33. McEwen BS. Effects of adverse experiences for brain structure and function. Biol Psychiatry 2000; 15: 721-731.
34. Kim JJ, Diamond DM. The stressed hippocampus, synaptic plasticity and lost of memories. Nat Rev Neurosci 2002; 3: 453-462.
35. Cameron HA, Woolley CS, McEwen BS, Gould E. Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience 1993; 56: 337-344.
36. Seki T, Arai Y. Highly polysialylated neural cell adhesion molecule (NCAM-H) is expressed by newly generated granule cells in the dentate gyrus of the adult rat. J Neurosci 1993; 13: 2351-2358.
37. Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 1999; 2: 260-265.
38. Cooper-Kuhn C, Kuhn HG. Is it all DNA repair? Methodological considerations for detecting neurogenesis in the adult brain. Brain Res Dev Brain Res 2002; 134: 13-21.
39. Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen B. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 1992; 222: 157-162.
40. Magarinos AM, Deslandes A, McEwen BS. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999; 371: 113-122.
41. Sheline YI, Wany P, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93: 3908-3913.
42. Bremmer JD, Randall P, Scott TM, Bronen RA, Seibyl JP, Southwick SM et al. MRI-based measurement of hippocampal volume in patients with combat-related post-traumatic stress disorder. Am J Psychiatry 1995; 152: 973-981.
43. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001; 25: 836-844.
44. Cameron HA, McEwen BS, Gould E. Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus. J Neurosci 1995; 15: 4687-1692.
45. Brezun JM, Daszuta A. Depletion of serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 1999; 89: 999-1002.
46. Radley JJ, Jacobs BL. 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res 2002; 955: 264-267.
47. Gully D, Geslin M, Serva L, Fontaine E, Roger P, Lair C et al. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4- methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization. J Pharmacol Exp Ther 2002; 301: 322-332.
48. Hernando F, Schoots O, Lolait SJ, Burbach JP. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 2001; 142: 1659-1668.
49. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 1996; 17: 166-172.